CalciMedica, Inc.
CALC$12M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaLA JOLLA
Drugs in Pipeline
5
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Apr 15, 2026
4wMarket Overview
Stock performance and key metrics
CALC News
Catalyst Timeline
1 upcoming, 1 past
Drug Pipeline
Auxora
Acute Kidney Injury
Auxora (Part 1)
Pneumonia
CM4620-IE
Acute Pancreatitis
CM-4620 Injectable Emulsion or CM-4620-IE
Acute Pancreatitis
CM4620 Injectable Emulsion (Low Dose)
Acute Pancreatitis
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Auxora | Phase 2 | Acute Kidney Injury | - | - |
Auxora (Part 1) | Phase 2 | Pneumonia | - | - |
CM4620-IE | Phase 2 | Acute Pancreatitis | - | - |
CM-4620 Injectable Emulsion or CM-4620-IE | Phase 2 | Acute Pancreatitis | - | - |
CM4620 Injectable Emulsion (Low Dose) | Phase 2 | Acute Pancreatitis | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply